Concepedia

Primary Prevention of Coronary Heart Disease: Guidance From Framingham

Scott M. Grundy, Gary Balady, Michael H. Criqui, Gerald F. Fletcher, Philip Greenland, Loren F. Hiratzka, Nancy Houston-Miller, Penny M. Kris‐Etherton, Harlan M. Krumholz, John C. LaRosa,

Circulation · 1998 · 615 citations · 168 references

DOI

Concepts

Abstract

This statement discusses the new Framingham Heart Study charts for estimating (CHD) coronary heart disease risk, their essential features, and their appropriate use. In addition, several issues related to CHD prevention raised by these charts are examined. Other issues of risk management not considered in these charts are also addressed.

References

168

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy · JAMA · 1993 · 27.9K citations

, , +12

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

New England Journal of Medicine · 1993 · 24.7K citations · Full text

, , +14

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Anders Olsson, John J.V. McMurray, G Thorgeirsson et al. · The Lancet · 1994 · 8.5K citations

, , +13

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé et al. · New England Journal of Medicine · 1996 · 7.5K citations · Full text

, , +16

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

James Shepherd, Stuart M. Cobbe, Ian Ford et al. · New England Journal of Medicine · 1995 · 7.5K citations · Full text

, , +12